UBS Group’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-117,255
Closed -$665K 11086
2025
Q3
$665K Sell
117,255
-738,047
-86% -$3.78M ﹤0.01% 5887
2025
Q2
$3.26M Buy
855,302
+527,887
+161% +$1.64M ﹤0.01% 4315
2025
Q1
$861K Sell
327,415
-709,864
-68% -$2.31M ﹤0.01% 5411
2024
Q4
$3.67M Buy
1,037,279
+1,017,775
+5,218% +$3.9M ﹤0.01% 4142
2024
Q3
$88.9K Buy
19,504
+10,734
+122% +$51.9K ﹤0.01% 6443
2024
Q2
$38.1K Sell
8,770
-25,464
-74% -$112K ﹤0.01% 6896
2024
Q1
$172K Buy
34,234
+4,739
+16% +$26.5K ﹤0.01% 5954
2023
Q4
$185K Buy
29,495
+14,963
+103% +$85.7K ﹤0.01% 5823
2023
Q3
$103K Sell
14,532
-2,165
-13% -$17.1K ﹤0.01% 5814
2023
Q2
$170K Buy
+16,697
New +$174K ﹤0.01% 5595
2023
Q1
Sell
-3,090
Closed -$22.2K 10278
2022
Q4
$22.2K Buy
+3,090
New +$18.9K ﹤0.01% 7550
2022
Q3
Sell
-2,152
Closed -$10K 10849
2022
Q2
$10K Buy
2,152
+1,152
+115% +$5.7K ﹤0.01% 7992
2022
Q1
$6K Sell
1,000
-1,253
-56% -$6.15K ﹤0.01% 8992
2021
Q4
$11K Buy
2,253
+1,410
+167% +$7.76K ﹤0.01% 8683
2021
Q3
$6K Buy
843
+139
+20% +$831 ﹤0.01% 8442
2021
Q2
$4K Sell
704
-1,680
-70% -$10.1K ﹤0.01% 8689
2021
Q1
$16K Buy
2,384
+661
+38% +$4.53K ﹤0.01% 7579
2020
Q4
$9K Buy
1,723
+992
+136% +$7.77K ﹤0.01% 7572
2020
Q3
$5K Sell
731
-1,014
-58% -$7.92K ﹤0.01% 7333
2020
Q2
$13K Buy
1,745
+1,403
+410% +$12.3K ﹤0.01% 6843
2020
Q1
$3K Sell
342
-1,439
-81% -$10.4K ﹤0.01% 7514
2019
Q4
$10K Buy
+1,781
New +$9.11K ﹤0.01% 7291
2019
Q3
Sell
-4,211
Closed -$13K 8222
2019
Q2
$13K Buy
4,211
+1,551
+58% +$5.07K ﹤0.01% 6907
2019
Q1
$8K Sell
2,660
-19,082
-88% -$65.5K ﹤0.01% 6951
2018
Q4
$82K Buy
21,742
+19,915
+1,090% +$93.6K ﹤0.01% 5708
2018
Q3
$11K Buy
1,827
+156
+9% +$794 ﹤0.01% 7117
2018
Q2
$9K Buy
+1,671
New +$17.2K ﹤0.01% 7198
2018
Q1
Sell
-1,108
Closed -$13K 8118
2017
Q4
$13K Buy
+1,108
New +$15.6K ﹤0.01% 6870